CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed
Drug / intervention
potassium +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000501
NCT00000501Phase 2Completed
CompareCT.gov

Hypertension Prevention Trial (HPT) Feasibility Study

National Heart, Lung, and Blood Institute (NHLBI)·interventional·Posted Oct 28, 1999·Updated Nov 26, 2013

In Brief

A Phase 2 clinical trial evaluating diet, sodium-restricted, diet, reducing, and 1 other intervention for Cardiovascular Diseases and 4 related conditions. Completed.

Detailed Summary

To test the feasibility and the efficacy of nutritional interventions in the primary prevention of hypertension in individuals predisposed to the development of hypertension; specifically, to test the hypothesis that reduction of weight and/or decreased sodium intake in obese individuals, or decreased sodium intake with or without increased potassium intake (in men and women, regardless of weight) would prevent the elevation of blood pressure and the incidence of hypertension.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Heart Diseases, Hypertension, Obesity, Vascular Diseases
Countries--
Collaborators--

Timeline

Phase 2CompletedFinished
19811982198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 28, 1999
Enrollment StartSep 1, 1981
Study CompletionAug 1, 1986
TodayJul 2, 2026
Posted 26.7 years ago

Interventions

diet, sodium-restrictedbehavioral

diet, reducingbehavioral

potassiumdrug